Merck’s profitability was materially driven by Healthcare, which generated strong organic growth and the profitability line was additionally helped by some relief from costs. Life Science continued to perform very well. Performance Materials suffered from the decline in Liquid Crystals, as expected, which were not offset by a stronger OLED business and Semiconductor remained subdued. Reported figures were above our expectations and beat the street’s as well.
14 Nov 2019
Healthcare's strong pick-up
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Healthcare's strong pick-up
Merck KGaA (MRCK:WBO) | 0 0 1.2% | Mkt Cap: 10,792m
- Published:
14 Nov 2019 -
Author:
Martin Schnee -
Pages:
3
Merck’s profitability was materially driven by Healthcare, which generated strong organic growth and the profitability line was additionally helped by some relief from costs. Life Science continued to perform very well. Performance Materials suffered from the decline in Liquid Crystals, as expected, which were not offset by a stronger OLED business and Semiconductor remained subdued. Reported figures were above our expectations and beat the street’s as well.